ACLA,COMMENT,LETTER,FDA,LACKS,STATUTORY AUTHORITY,ILL,MOVE,LABORATORY,DEVELOPED,ABOUT US,MISSION,BOARD OF DIRECTORS,STAFF,ANNUAL MEETING,ECONOMIC IMPACT,PROTECTING ACCESS TO MEDICARE,REIMBURSEMENT,COVERAGE,PATIENT,ACCESS,LAB,VALUE,LABS,EXCEPTION,SELF,REFERRAL,HEALTH IT,DATA,STANDARDS,TRICARE,ACTION NEWS,PRESS RELEASES,COMMENTS,LETTERS,IN THE NEWS,RESOURCES,JOIN US,CONTACT,FEBRUARY 02,CATEGORIES,WASHINGTON DC,THE AMERICAN,ASSOCIATION,TODAY,SUBMITTED,THE FOOD AND DRUG,ADMINISTRATION,ADDRESSING,DRAFT,GUIDANCE,THE AGENCY,MISGUIDED,ATTEMPT,DEFINE,DIAGNOSTIC TESTING,MEDICAL DEVICES,EXISTING,REGULATION,INNOVATION,INDUSTRY,TESTING,MEDICAL DEVICE,TRYING,ROUND,SQUARE,HOLE,ALAN,PRESIDENT OF,ATTEMPTED,EXPANSION,AUTHORITY,INCONSISTENT,STATUTORY,TEXT,RAISE,CONSTITUTIONAL,QUESTIONS,CONGRESS,ITSELF,CRAFTING,THE CURRENT,FRAMEWORK,DIAGNOSTIC TESTS,PERFORMED,TRAINED,PROFESSIONALS,ENTITY,REGULATED,REQUIREMENTS,ENACTED,IMPROVEMENTS,CLIA,STATE,REGULATORS,PHYSICIANS,DEPEND,CRITICAL,INFORMATION,MEDICAL,DECISIONS,THE BEST,COURSE,PATIENTS,STAKEHOLDER,PERIOD,ENDING,FEBRUARY 2,RELY,RANGING,COMMON,PAP SMEARS,GRAM,ADVANCED,SOPHISTICATED,MOLECULAR,GENETIC,SEQUENCING,CANCER,HEART DISEASE,RARE,INFECTIOUS DISEASES,MOLECULAR DIAGNOSTICS,NEW ERA,PERSONALIZED MEDICINE,CONTINUE,ADVANCE,OPTIONS,ANXIOUSLY,HOLDING,ONTO,HOPE,SCIENCE,HELPING,MANKIND,INTENT,PASSAGES,DEFINITION OF,DEVICE,LEGISLATIVE HISTORY OF,AMENDMENTS,IMPROVEMENT,THE AUTHORITY,HAVE TO,NOTICE,RULEMAKING,RATHER,INFORMAL,PROCESS,IMPOSE,NOVEL,BINDING,THE PUBLIC,PHYSICAL,LESS,MOVING,COMMERCE,SHOE,HORNING,TANGIBLE,RULE,CONSTRUCTION,WORDS,COMPANIONS,DO NOT,SOMETIMES,MEDICAL COMMUNITY,EXPERIENCED,EXPLOSION,THE LAST,DECADES,GLOBAL IMPACT,DISEASE,INTERVENTION,CURES,FOREFRONT,DISCOVERIES,CHANGING,SAVING,LIVES,THE GLOBE,CALLING,IMPACT,FDA REGULATION,THE BRAKES,PROGRESS,ALTER,FUTURE,DISEASES,NEWS PRESS,MEDICARE ACT,FACT,THREATS,MEDIA,PHONE,EMAIL,ACTION,COALITION,ADDRESS,AMERICAN,NEW YORK,SUITE,WEST,